Cyclacel Pharmaceuticals, Inc.

Q2 2024 13F Holders

Symbol
CYCC
CUSIP
23254L801
Type
Equity
Class
COM NEW
Num filings
18
Total reported value, excl. options
$371 k
Manager Report Date Value ($000) Shares Option Type